Torno Capital »

Blueprint Medicines shares owned by Torno Capital

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Torno Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.5M 49k 92.24

More positions owned by Torno Capital

Sprott Fds Tr Uranium Miners E Put Option (URNM)
Spotify Technology S A SHS Put Option (SPOT)
Alphabet Cap Stk Cl A (GOOGL)
Global X Fds Global X Uranium Put Option (URA)
Ishares Msci Sth Kor Etf Put Option (EWY)
Colgate-Palmolive Company Put Option (CL)
Caterpillar Call Option (CAT)
BlackRock Call Option (BLK)
Booz Allen Hamilton Hldg Cor Cl A Call Option (BAH)
United States Stl Corp New Com Put Option (X)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Incyte Corporation Call Option (INCY)
Realty Income Call Option (O)
Rio Tinto Sponsored Adr Call Option (RIO)
Regeneron Pharmaceuticals Put Option (REGN)

View all positions for Torno Capital

Top funds holding Blueprint Medicines

Vanguard Group
T. Rowe Price Associates
Wellington Management Company
William Blair Investment Management
Jpmorgan Chase & Co
Lord, Abbett & Co
Alliancebernstein
Brown Advisory Holdings Incorporated
Avidity Partners Management
Norges Bank Investment Management
Goldman Sachs Group
Charles Schwab Investment Management
Emerald Advisers
Point72 Asset Management
Bank of America Corporation

View all funds holding Blueprint Medicines